NYSE:SNY - Sanofi SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$44.93 -0.01 (-0.02 %)
(As of 11/20/2018 10:49 AM ET)
Previous Close$44.94
Today's Range$44.67 - $44.98
52-Week Range$37.43 - $46.25
Volume58,003 shs
Average Volume1.54 million shs
Market Capitalization$113.11 billion
P/E Ratio14.27
Dividend Yield2.67%
Beta0.7

SEC Filings

Sanofi (NYSE:SNY) SEC Filings

DateFilerForm TypeView
11/13/2018
5:20 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
11/07/2018
7:24 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/31/2018
2:30 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/22/2018
7:58 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
10/01/2018
2:14 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/14/2018
8:33 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
09/10/2018
4:01 PM
REGENERON PHARMACEUTICALS INC (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/05/2018
7:46 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
07/31/2018
12:25 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
07/31/2018
8:40 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
07/26/2018
7:27 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/29/2018
6:43 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/28/2018
8:05 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/20/2018
5:12 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/19/2018
1:15 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/19/2018
5:38 AM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC 13D/A
View Filing
06/19/2018
5:34 AM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC TO-T/A
View Filing
06/14/2018
2:36 PM
Sanofi (Filer)
Form 424B5
View Filing
06/13/2018
10:13 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/12/2018
4:30 PM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC TO-T/A
View Filing
06/12/2018
7:30 AM
Sanofi (Filer)
Form 424B5
View Filing
06/12/2018
7:21 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/11/2018
5:52 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
06/08/2018
1:08 PM
Sanofi (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
06/07/2018
6:26 AM
Sanofi (Filer)
Form 6-K/A
View Filing
06/05/2018
10:06 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/30/2018
5:36 AM
Sanofi (Filer)
Form SD
Specialized Disclosure Report  
View Filing
05/29/2018
3:34 PM
MyoKardia Inc (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/25/2018
5:39 AM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC 13D
View Filing
05/22/2018
8:29 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
05/18/2018
3:32 PM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC TO-T/A
View Filing
05/15/2018
7:44 AM
Sanofi (Filer)
Form S-8 POS
View Filing
05/14/2018
7:02 AM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC TO-T/A
View Filing
05/07/2018
7:14 AM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC TO-T/A
View Filing
05/03/2018
8:23 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/27/2018
1:28 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/24/2018
9:13 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/18/2018
5:12 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
04/04/2018
6:50 AM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC TO-T
View Filing
04/03/2018
7:15 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/29/2018
1:13 PM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC TO-C
View Filing
03/29/2018
8:51 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/16/2018
6:55 AM
Sanofi (Filer)
Form 20-F/A
View Filing
03/15/2018
10:10 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/12/2018
10:28 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/08/2018
12:14 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/08/2018
7:04 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/08/2018
5:10 AM
Bioverativ Inc. (Subject)
Sanofi (Filed by)
Form SC TO-T/A
View Filing
03/07/2018
12:57 PM
Sanofi (Filer)
Form IRANNOTICE
View Filing
03/07/2018
12:39 PM
Sanofi (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
View Filing
03/06/2018
2:16 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/02/2018
8:02 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
03/01/2018
2:01 PM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC TO-C
View Filing
02/23/2018
3:03 PM
Bioverativ Inc. (Subject)
Sanofi (Filed by)
Form SC TO-T/A
View Filing
02/20/2018
4:31 PM
Bioverativ Inc. (Subject)
Sanofi (Filed by)
Form SC TO-T/A
View Filing
02/20/2018
1:47 PM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC TO-C
View Filing
02/13/2018
3:58 PM
Regulus Therapeutics Inc. (Subject)
Sanofi (Filed by)
Form SC 13G/A
View Filing
02/13/2018
3:55 PM
ALNYLAM PHARMACEUTICALS, INC. (Subject)
Sanofi (Filed by)
Form SC 13G/A
View Filing
02/13/2018
3:55 PM
MyoKardia Inc (Subject)
Sanofi (Filed by)
Form SC 13G/A
View Filing
02/09/2018
4:06 PM
Bioverativ Inc. (Subject)
Sanofi (Filed by)
Form SC TO-T/A
View Filing
02/08/2018
3:51 PM
Bioverativ Inc. (Subject)
Sanofi (Filed by)
Form SC TO-T/A
View Filing
02/08/2018
8:48 AM
BlackRock Inc. (Filed by)
Sanofi (Subject)
Form SC 13G/A
View Filing
01/30/2018
4:12 PM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC TO-C
View Filing
01/29/2018
11:33 AM
Ablynx NV (Subject)
Sanofi (Filed by)
Form SC TO-C
View Filing
01/29/2018
8:02 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/22/2018
3:57 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/22/2018
3:40 PM
Bioverativ Inc. (Subject)
Sanofi (Filed by)
Form SC TO-C
View Filing
01/22/2018
10:26 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
01/09/2018
4:20 PM
REGENERON PHARMACEUTICALS INC (Subject)
Sanofi (Filed by)
Form SC 13D/A
View Filing
01/08/2018
10:47 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/18/2017
11:01 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/13/2017
3:06 PM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
12/05/2017
11:45 AM
Sanofi (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
View Filing
This page was last updated on 11/20/2018 by MarketBeat.com Staff

Featured Article: Fundamental Analysis

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel